Spurr Robert
- SEC CIK
- 0001543795
No open-market purchases or sales filed in the past year.
Current role at each company
- BHC Bausch Health Companies Inc.President, U.S. Businessesas of May 12, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Spurr Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2022 (view filing) | Apr 14 | 1 day | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −1.59K | $22.19 | −$35.4K | −1.7%90.5K after | |
| Mar 16, 2022 (view filing) | Mar 15 | 1 day | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −4.85K | $22.20 | −$107.6K | −5.0%92.1K after | |
| Mar 4, 2022 (view filing) | Mar 2 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −1.59K | $23.37 | −$37.3K | −2.4%65.4K after | |
| Feb 17, 2022 (view filing) | Feb 15 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −3.25K | $25.02 | −$81.3K | −5.1%60.3K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Spurr RobertU.S. President-Pharma Business | SSaleCommon Shares, No Par Value | −3.25K | $26.63 | −$86.6K | −4.9%63.5K after |